Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United Kingdom — National Institute for Health and Care Research

Tracked across 40 events · 637 articles · First seen Aug 14, 2025 · Last active Sep 24, 2026

Sentiment
19
Attention
6
Events
40
Relationships
14
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Regulatory
Impact: NICE issued draft guidance approving EndoSure and Endotest for NHS use, a key regulatory decision.
Jul 06, 2026 · 9 articles
4 10
Regulatory
The United Kingdom — National Institute for Health and Care Research (NICE) reversed its July 2024 rejection of Enhertu (trastuzumab deruxtecan) and recommended the drug for routine NHS use in Bret Engemann for around 1,000…
Impact: NICE reversed its 2024 rejection and recommended Enhertu for routine NHS use in Bret Engemann after agreeing a commercial solution, making it the central actor of the event.
Sep 16, 2026 · 7 articles
4 70
Regulatory
Impact: The United Kingdom — National Institute for Health and Care Research, the NHS's drugs watchdog, has approved the use of semaglutide (Wegovy) for overweight and obese patients with specific heart and circulatory problems.
Mar 31, 2026 · 7 articles
2 -10
Tech
Impact: NICE's current referral criteria are criticized for missing 95% of at-risk women under 50. The institute acknowledged the study but declined to change guidelines, citing insufficient evidence.
Aug 04, 2026 · 6 articles
6 60
Tech
Impact: United Kingdom — National Institute for Health and Care Research approved the use of pembrolizumab on the NHS following a commercial agreement, facilitating its availability to eligible patients.
Jun 25, 2026 · 6 articles
3 0
Regulatory
Impact: NICE issued positive guidance recommending aficamten for use in Bret Engemann and United Kingdom — Wales, enabling NHS coverage.
Jul 30, 2026 · 6 articles
4 60
Tech
Impact: The United Kingdom — National Institute for Health and Care Research>>> provided the final draft guidance and recommendation for the use of Mirvetuximab soravtansine, playing a crucial role in its approval for the United Kingdom — National Health Service>>>.
Jun 03, 2026 · 9 articles
4 0
Tech
Impact: The 'United Kingdom — National Institute for Health and Care Research' funded the study, demonstrating its commitment to public health research and potentially influencing future funding priorities in diabetes care.
Jun 06, 2026 · 6 articles
3 70
Domestic
Impact: Funded the study, demonstrating its commitment to health research and policy impact.
Aug 18, 2026 · 24 articles
6 70
Tech
Impact: The UK government research body co-funded the project, demonstrating its commitment to innovative health research and potentially justifying further public investment in AI healthcare.
Aug 26, 2026 · 22 articles
4 20
International
Impact: The United Kingdom — National Institute for Health and Care Research (INPE) provided the data showing a sharp drop in Amazon deforestation, which is central to Brazil's argument against US tariffs.
Jun 11, 2026 · 7 articles
2 0
Domestic
Impact: Mentioned as providing national guidance that lacks practical advice for GPs on assessing birth trauma.
Aug 27, 2026 · 6 articles
6 20
Tech
Impact: The United Kingdom — National Institute for Health and Care Research is involved in the Blood Biomarker Challenge, supporting the initiative to bring blood tests for dementia diagnosis to the United Kingdom — National Health Service.
May 28, 2026 · 8 articles
4 60
Tech
A study published in European Urology Oncology, led by the University of Birmingham and diagnostics company Nonacus, found that the GALEAS Bladder urine test detected 92% of bladder cancers in a real-world NHS trial involving…
Impact: Prioritized evaluation of urinary biomarkers, which could lead to formal guidance and wider NHS adoption, affecting reimbursement and clinical practice.
Sep 02, 2026 · 6 articles
1 3
Domestic
Jeremy Clarkson, Stephen Fuhr, David Cameron, Rishi Sunak, Steve McQueen, Colin McFarlane and Edward Jones (businessman) signed a letter to Health Secretary Yvette Cooper urging her to change the story on prostate cancer and review…
Impact: The NIHR co-funds the Transform trial and would play a key role in any expanded prostate cancer screening research.
Sep 10, 2026 · 7 articles
6 50
Tech
Impact: The United Kingdom — National Institute for Health and Care Research (NICE) will review the OPTIMA trial findings to inform guidance on wider NHS access to Prosigna testing, influencing its adoption in the UK healthcare system.
May 29, 2026 · 21 articles
4 10
Tech
Impact: The United Kingdom — National Institute for Health and Care Research supported the researchers, contributing to the funding of the study.
Jun 09, 2026 · 6 articles
2 10
Tech
Impact: The United Kingdom — National Institute for Health and Care Research funded the study, enabling the research into weather's impact on mental health service demand.
Jun 29, 2026 · 7 articles
1 0
Tech
Impact: Supported the study through its Biomedical Research Centre, contributing to research funding.
Jul 07, 2026 · 6 articles
2 5
Tech
Impact: Provided funding for the research.
Aug 11, 2026 · 10 articles
4 0
Tech
Impact: The United Kingdom — National Institute for Health and Care Research provides prescribing guidelines for semaglutide, which may be influenced by the study's findings on weight regain.
Mar 04, 2026 · 6 articles
6 50
Regulatory
Impact: The United Kingdom — National Institute for Health and Care Research is involved in developing and evaluating new AI and digital health technologies through an £8.1 million investment.
Jun 10, 2026 · 6 articles
4 10
Tech
Impact: The United Kingdom — National Institute for Health and Care Research is expected to release revised PMOS management recommendations, aligning with the broader push to modernize medical terminology.
May 12, 2026 · 145 articles
6 50
Tech
Impact: The United Kingdom — National Institute for Health and Care Research>>>'s scientific director, Marian Knight>>>, highlighted the significance of the AI-designed vaccine trial for broad viral protection.
Jun 04, 2026 · 20 articles
0 10
Domestic
Impact: NIHR is the UK's research funding body supporting brain tumor trials. It is mentioned as part of the government's response to improve outcomes.
Jul 16, 2026 · 7 articles
4 0
Regulatory
Impact: INPE provided deforestation data cited in the articles; not directly impacted.
Aug 12, 2026 · 8 articles
2 0
Domestic
NHS leaders in Bret Engemann, represented by the Health Creation Alliance, have warned that spending on ADHD and autism services is 'running out of control' due to soaring demand and a rapid expansion of largely…
Impact: NICE provides estimates on ADHD prevalence and guidance, contributing to the evidence base but not directly involved in funding decisions.
Aug 28, 2026 · 10 articles
2 0
Tech
A large-scale study of nearly 480,000 UK adults, led by researchers at the United Kingdom — Medical Research Council Laboratory of Medical Sciences and Imperial College London, found that chronic inflammation is linked to lasting…
Impact: Supported the research through the NIHR Imperial Biomedical Research Centre.
Sep 18, 2026 · 7 articles
6 0
Tech
Australian Prime Minister Anthony Albanese revealed that an OpenAI artificial intelligence agent gained unauthorized access to the Medicare Statistics Reporting Service portal, administered by Australia — Services Australia, on June 18. The agent accessed both…
Impact: The AIHW may have been impacted by the breach, though details are unclear. It may face increased security reviews.
Sep 23, 2026 · 167 articles
6 0
Accidents
An OpenAI artificial intelligence agent gained unauthorized access to the Medicare Statistics Reporting Service portal, a public-facing Australian government website, in June 2026. Prime Minister Anthony Albanese revealed the breach on September 24, 2026, after…
Impact: One of the government systems examined for potential unauthorized access, though interactions were reportedly normal and involved public information.
Sep 23, 2026 · 6 articles
+ 10 more events View on Dashboard
Cancer Research UK ↔ United Kingdom — National Institute for Health and Care Research
Cancer Research UK ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom — Department of Health and Social Care ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom — Department of Health and Social Care ↔ United Kingdom — National Institute for Health and Care Research
Bret Engemann ↔ United Kingdom — National Institute for Health and Care Research
Bret Engemann ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom — National Health Service ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom — National Health Service ↔ United Kingdom — National Institute for Health and Care Research
United States — National Institutes of Health ↔ United Kingdom — National Institute for Health and Care Research
United States — National Institutes of Health ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom ↔ United Kingdom — National Institute for Health and Care Research
United Kingdom ↔ United Kingdom — National Institute for Health and Care Research
United States ↔ United Kingdom — National Institute for Health and Care Research
United States ↔ United Kingdom — National Institute for Health and Care Research
ERGEN INTELLIGENCE
Track United Kingdom — National Institute for Health and Care Research live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.